12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 5 16:05 ET

Mizuho Securities Maintains Adverum Biotechnologies(ADVM.US) With Buy Rating, Cuts Target Price to $16

Moomoo NewsNov 22 14:31 ET · Ratings

Adverum Biotechnologies Price Target Lowered to $16 From $20 at Mizuho

TipRanksNov 22 13:45 ET

Mizuho Securities Cuts Price Target on Adverum Biotechnologies to $16 From $20, Outperform Rating Maintained

MT NewswiresNov 22 13:28 ET · Ratings

Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireNov 20 16:05 ET

Express News | Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

ReutersNov 20 16:05 ET